Please assess the completion status of the following clinical trial:

Trial Title: Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Confirmed COVID-19 infection~2. Age =/\>40 or diabetes or known coronary disease or hypertension~3. Requires hospital admission for further clinical management.~Exclusion Criteria:~1. Clear evidence of an acute coronary syndrome or myo-pericarditis that requires specific treatment that precludes randomization.~2. Evidence of active bleeding~3. Pregnancy.~4. Age \<18 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Active Arm (Type: EXPERIMENTAL): None
- Control Arm (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).